• Contact Us
Saturday, March 25, 2023
Health Business
Advertisement
  • Home
  • News
    With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB

    With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB

    New TB research may lead to ‘perfect drug’

    WORLD TB DAY – Yes! We can end TB

    Major supermarkets in Kenya selling superbug laden meat, new study shows

    Major supermarkets in Kenya selling superbug laden meat, new study shows

    Zipline unveils new autonomous system capable of quiet, fast and precise home delivery

    Zipline unveils new autonomous system capable of quiet, fast and precise home delivery

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
  • Home
  • News
    With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB

    With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB

    New TB research may lead to ‘perfect drug’

    WORLD TB DAY – Yes! We can end TB

    Major supermarkets in Kenya selling superbug laden meat, new study shows

    Major supermarkets in Kenya selling superbug laden meat, new study shows

    Zipline unveils new autonomous system capable of quiet, fast and precise home delivery

    Zipline unveils new autonomous system capable of quiet, fast and precise home delivery

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
No Result
View All Result
Health Business
No Result
View All Result

Roche partners with the U.S CDC in fight against HIV, TB in Africa

by Samwel Doe Ouma
March 1, 2023
in News
0
New study finds no link between HIV infection and contraceptive methods

PHOTO: COURTESY

Share This:

Roche has announced the expansion of its collaboration with the U.S. Centers for Disease Control and Prevention (CDC) to strengthen laboratory capabilities in countries greatly affected by the HIV and tuberculosis (TB) epidemics.

Through the implementation of a public-private partnership (PPP), named “Lab Networks for Health,” Roche and the CDC will seek to improve HIV and
tuberculosis prevention, detection, and treatment outcomes in select countries of Africa, Eastern Europe, Central Asia, and the Western Hemisphere (e.g. Latin America, Central America, and Caribbean Regions).

Specifically, Roche and CDC intend to increase laboratory human resource capacity building through expanded training interventions and to support laboratory quality management systems and improvement programs.

The partners will also seek to optimise laboratory workflows and integrated diagnostics networks to increase access to multi-pathogen testing capabilities to enhance pandemic preparedness. In addition, they will work to improve local and regional capacity for effective laboratory waste management and related biosafety
approaches.

”We are proud to continue our longstanding partnership with the U.S. Centers for Disease Control and Prevention to further support efforts that scale up and expand access to diagnostics for tuberculosis, HIV, and emerging pandemics”, said Bernard Colombo, President Europe Middle East, Africa, and Latin America of Roche Diagnostics.”

Investments in strong laboratory networks contribute to the strengthening of health systems that enable people to have access to life-saving testing and treatment for improved disease management and quality of life.”

“CDC’s global laboratory-supported systems and networks are critical for detecting and
monitoring HIV and tuberculosis and have also been vital in the response to COVID-19 and other disease outbreaks,” said Dr. Hank Tomlinson, Director of CDC’s Division of Global HIV and TB.

“Our renewed partnership with Roche Diagnostics will help to sustain these
essential platforms, enhance laboratory workforce capacity, and identify efficiencies in
multi-disease public health laboratory systems to ensure accurate, reliable, and responsive diagnostic services globally.”

All activities under the PPP will be developed in a manufacturer-agnostic and collaborative manner among representatives from CDC, including country offices, pRoche global and regional offices, and host country Ministries of Health, with the goal of creating and improving local and regional institutional capacity for laboratory systems strengthening.

The COVID-19 pandemic has impacted progress towards reaching the World Health Organization (WHO) HIV and tuberculosis elimination goals and brought challenges to health care systems across countries and communities, putting lives at risk. A recent UNAIDS report highlighted the faltering progress of HIV programs, with approximately 1.5 million new infections occurring in 2021; more than 1 million over the global target.

Reversing years of declines, about 10.6 million people worldwide became ill with tuberculosis in 2021, and only 6.4 million of them were diagnosed, according to global reporting.

Share This:
Previous Post

Vitality Health International launches ‘one-of-its-kind’ health insurance program in Kenya

Next Post

KEMRI study reveals barriers to compliance with the WHO preventive measures messaging at the onset of COVID‐19

Related Posts

KEMRI announces new T.B vaccine and shorter T.B treatment regimen promise
Providers

KEMRI announces new T.B vaccine and shorter T.B treatment regimen promise

March 24, 2023
With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB
News

With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB

March 24, 2023
New TB research may lead to ‘perfect drug’
News

WORLD TB DAY – Yes! We can end TB

March 24, 2023
Next Post
KEMRI study reveals barriers to compliance with the WHO preventive measures messaging at the onset of COVID‐19

KEMRI study reveals barriers to compliance with the WHO preventive measures messaging at the onset of COVID‐19

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Follow Us

Most Read

  • Major supermarkets in Kenya selling superbug laden meat, new study shows

    Major supermarkets in Kenya selling superbug laden meat, new study shows

    0 shares
    Share 0 Tweet 0
  • Zipline set to launch its full operations in Kenya to drive timely delivery of medical supplies using drone technology

    0 shares
    Share 0 Tweet 0
  • Gynocare Women’s and Fistula Hospital an ‘oasis’ of hope for the poor

    0 shares
    Share 0 Tweet 0
Health Business

Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.

Top Stories

KEMRI announces new T.B vaccine and shorter T.B treatment regimen promise

KEMRI announces new T.B vaccine and shorter T.B treatment regimen promise

March 24, 2023
With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB

With TB Response Rebounding from the COVID-19 Pandemic Downturn, World TB Day 2023 Marks the Start of a New Era: Yes! We Can End TB

March 24, 2023
New TB research may lead to ‘perfect drug’

WORLD TB DAY – Yes! We can end TB

March 24, 2023

Interests

  • Events
  • Finance
  • Government
  • Magazines
  • Medical Research
  • News
  • Politics & Policy
  • Providers
  • Public Health
  • Regulation, Enforcement & Compliance
  • Technology
  • Videos

Follow Us

  • Contact Us

© 2019 | Site by Mark & Ryse.

No Result
View All Result
  • Home
  • News
  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos

© 2019 | Site by Mark & Ryse.